Formaldehyde-induced paxillin–tyrosine phosphorylation and paxillin and P53 downexpression in Hela cells. (12th February 2016)

• Record Type: Journal Article
• Authors: Zhao, Yun; Wei, Chenxi; Wu, Yang; Ma, Ping; Ding, Shumao; Yuan, Junlin; Shen, Dingwen; Yang, Xu
• Is Part Of: Toxicology mechanisms and methods. Volume 26:Number 2(2016)
• Page Start: 75
• Page End: 81
• Publication Date: 2016-02-12
• Subjects: Formaldehyde -- Hela cell -- immunofluorescence -- P53 -- paxillin -- phosphotyrosine -- Western blot; Analytical toxicology -- Periodicals; Toxicology -- Periodicals; Toxicology -- Methodology -- Periodicals; 615.907
• DOI: 10.3109/15376516.2015.1082001
• Languages: English
• ISSNs: 1537-6516

Abstract

Abstract: Formaldehyde (FA) is an environmental pollutant and an endogenous product believed to be involved in tumorigenesis. However, the underlying mechanism of observed FA effects has not been clearly defined. Paxillin is a focal adhesion protein that may play an important role in several signaling pathways. Many paxillin-interacting proteins are involved in the regulation of actin cytoskeleton organization, which is necessary for cell motility events associated with diverse biological responses, such as embryonic development, wound repair and tumor metastasis. P53 is important in multicellular organisms, where it regulates the cell cycle and thus functions as a tumor suppressor that is involved in preventing cancer. In this study, we investigated the effects of FA on paxillin–tyrosine phosphorylation and P53 expression in Hela cells by Western blot and immunofluorescence. Western blot analysis revealed that nonlethal concentrations of FA (0.5, 1.0 and 2.0 mM, with the exposure time for 0.5, 1.0 and 2.0 h, respectively) had downregulated paxillin and wild-type p53 genes expression while upregulated paxillin–tyrosine phosphorylation significantly. At the same time, phosphotyrosine at the focal adhesion sites detected by immunofluorescence assay obviously increased in Hela cells incubated with 2.0 mM FA for 2 h. The results suggested that paxillin and p53 genes expression may be involved in FA-related adverse effects and the mechanism may be involved in paxillin–tyrosine phosphorylation.